ITGAX and neoplasm: Nonreplicating uracil auxotrophs also preferentially target and invade CD11c+ and myeloid cell populations in aggressive models of murine pancreatic cancer, melanoma, and ovarian cancer to convert tolerogenic tumor microenvironments into immune stimulatory microenvironments [15,16,19,20].